期刊文献+

2型糖尿病肾病患者血清Chemerin与SOD、MDA的临床分析 被引量:7

Analysis between plasma chemerin and SOD、MDA in patients with Type 2 diabetic nephropathy
下载PDF
导出
摘要 目的本研究旨在探讨2型糖尿病不同程度肾病与chemerin、SOD及MDA的相关性。方法选取2016年1月—2017年12月期间于广州市第一人民医院内分泌科门诊和住院的患者100例,根据尿白蛋白/肌酐比(ACR)分为正常尿蛋白组(NA组,n=33),微量白蛋白尿组(MA组,n=34)及大量蛋白尿组(CA组,n=33),另选取32例我院体检中心体检结果正常的正常健康人作为对照组(NC组,n=32),测定血糖、糖化血红蛋白、血肌酐、ACR、24小时尿蛋白定量、胆固醇、甘油三酯、SOD、MDA、chemerin等水平。结果 SOD的水平:NC组> NA组> MA组>CA组(P<0.05);MDA的水平:CA组>MA组>NA组>NC组(P<0.05);Chemerin水平:CA组>MA组>NA组>NC组(P<0.05)。相关性分析提示ACR与血清SOD呈负相关,与MDA、chemerin呈正相关。多元回归分析显示,病程、胆固醇、糖化血红蛋白、chemerin是影响ACR的主要因素。结论 Chemerin、MDA、SOD可能参与糖尿病肾病的发生发展,检测其水平可以在一定程度上反映2型糖尿病肾病患者的病情严重程度。 Objective To explore the relationship between different type of Type 2 diabetes nephropathy and chemerin,SOD,MDA. Methods A total of 100 inpatients and outpatients were enrolled in this study between January 2016 and December 2017 in Guangzhou First People s Hospital. They were divided into normal urinary protein group (NA group, n =33), microalbuminuria group (MA group, n =34) and massive proteinuria group (CA group, n =33) based on ACR. Another 32 healthy people were collected as a control group in medical examination center (NC group, n =32). The levels of blood sugar, glycated hemoglobin, serum creatinine, ACR, 24-hour urinary protein, cholesterol, triglyceride, SOD, MDA and chemerin were measured. Results The level of SOD: NC group > NA group > MA group > CA group ( P < 0.05). The level of MDA: CA group > MA group > NA group > NC group ( P < 0.05). The level of chemerin: CA group > MA group > NA group > NC group ( P < 0.05). Correlation analysis showed that ACR was negatively correlated with serum SOD and positively correlated with MDA and chemerin. Multivariate logistic regression demonstrated that course of disease, CHOL, HbA1c and chemerin were the main factors affecting ACR. Conclusion Chemerin, MDA and SOD may be involved in the occurrence and development of diabetic nephropathy. Chemerin, MDA and SOD may reflect the severity of type 2 diabetic nephropathy.
作者 卢建文 银孟卓 LU Jianwen;YIN Mengzhuo(Guangzhou First People's Hospital,Guangzhou 510180,China)
出处 《广州医药》 2019年第2期7-10,共4页 Guangzhou Medical Journal
基金 广州市卫生和计划生育科技项目(20181A011009)
关键词 糖尿病肾病 CHEMERIN SOD MDA Diabetic nephropathy Chemerin Superoxidedismutase (SOD) Malondiadehyde (MDA)
  • 相关文献

参考文献4

二级参考文献33

  • 1李孜,苏白海,米绪华,刘先蓉,樊均明.尿毒症炎症、氧化应激和羰基应激状态的相关性分析[J].四川大学学报(医学版),2006,37(1):123-125. 被引量:13
  • 2Thorp ML.Diabetic nephropathy:common questions[J].Am Fam Physician,2005,72(1):96-99.
  • 3Fu Y,Luo N,Klein RL,et al.Adiponectin promotes adipecyte differentiation,insulin sensitivity,and lipid accumulation[J].J Lipid Res,2005,46(7):1369-1379.
  • 4Kopp HP,Krzyzanowska K,Mohlig M,et al.Effects of marked weight loss on plasma levels of adiponectin,markers of chronic subclinical inflammation and insulin resistance in morbidly obese women[J].Int J Obes,2005,29(7):766-771.
  • 5Tsuzura S,Ikeda Y,Suehiro T,et al.Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonsse in patients with type 2 diabetes[J].Metabolism,2004,53(3):297-302.
  • 6Kowluru RA,Abbas SN,Odenbach S.Reversal of hyperglycaemia and diabetic nephropathy:effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats[J].Diabetes Complications,2004,18(9):282-288.
  • 7Fioretyo P, Mauer M. Histopathology of diabetic nephmpatIly[J]. Semin Nephrol, 2007,27 : 195.
  • 8Zelnanovitz T, Paggi A, Gross L, et al. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy[J]. Diabetes Care, 1997,20:516.
  • 9Bottini PV, Ribeiro Alves MA, Garlipp CR. Elctrophoretic pattern of concentrated urine] comparison between 24 hour collection an random sample[J]. Am J Kidney Dis,2002,39(1) :E2.
  • 10EndlichN, KrcssKR, ReiserI, et al. Podocytes responded to me- chanical in vitrol-17.1 Am See Neohrol,2001,12,41a.

共引文献124

同被引文献69

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部